LEADER 05057nam 2200637 450 001 9910797488003321 005 20200520144314.0 010 $a1-58528-493-9 035 $a(CKB)3710000000451349 035 $a(EBL)3425660 035 $a(SSID)ssj0001521184 035 $a(PQKBManifestationID)12630997 035 $a(PQKBTitleCode)TC0001521184 035 $a(PQKBWorkID)11530384 035 $a(PQKB)10267530 035 $a(Au-PeEL)EBL3425660 035 $a(CaPaEBR)ebr11081606 035 $a(OCoLC)914474047 035 $a(MiAaPQ)EBC3425660 035 $a(EXLCZ)993710000000451349 100 $a20150807h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aInfectious disease $epharmacotherapy self assessment /$fLea S. Eiland, PharmD, BCPS, FASHP, FPPAG, Diane B. Ginsburg, PhD, FASHP 210 1$aBethesda, Maryland :$cAmerican Society of Health-System Pharmacists,$d2015. 210 4$dİ2015 215 $a1 online resource (208 p.) 300 $aDescription based upon print version of record. 311 $a1-58528-492-0 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aTitle Page; Dedication; CONTENTS; PREFACE; ACKNOWLEDGMENTS; PART 1 | CASES; SECTION 1 | Bone and Joint/Skin and Soft Tissue; CASE 1.1 Acute Osteomyelitis | Level 1; Demographics; Physical Examination; Laboratory and Diagnostic Tests; Diagnosis; Notes; SELF-ASSESSMENT QUESTIONS; CASE 1.2 Skin and Soft Tissue Infection | Level 2; Demographics; Physical Examination; Laboratory and Diagnostic Tests; Diagnosis; Medication Record; SELF-ASSESSMENT QUESTIONS; CASE 1.3 Diabetic Foot Infection | Level 3; Demographics; Physical Examination; Laboratory and Diagnostic Tests; Diagnosis; Medication Record 327 $aSELF-ASSESSMENT QUESTIONSSECTION 2 | Gastrointestinal and Central Nervous System; CASE 1.4 Gastrointestinal Infection-Clostridium difficile | Level 1; Demographics; Physical Examination; Laboratory and Diagnostic Tests; Diagnosis; SELF-ASSESSMENT QUESTIONS; CASE 1.5 Gastrointestinal Infection-Shigella | Level 2; Demographics; Physical Examination; Laboratory and Diagnostic Tests; Diagnosis; Medication Record; SELF-ASSESSMENT QUESTIONS; CASE 1.6 Meningitis | Level 2; Demographics; Physical Examination; Laboratory and Diagnostic Tests; Diagnosis; Medication Record; SELF-ASSESSMENT QUESTIONS 327 $aCASE 1.7 Neurosyphilis | Level 3Demographics; Physical Examination; Laboratory and Diagnostic Tests; Diagnosis; Medication Record; SELF-ASSESSMENT QUESTIONS; SECTION 3 | Pulmonary; CASE 1.8 Acute Otitis Media | Level 1; Demographics; Physical Examination; Laboratory and Diagnostic Tests; Diagnosis; Medication Record; SELF-ASSESSMENT QUESTIONS; CASE 1.9 Acute Otitis Externa | Level 1; Demographics; Physical Examination; Laboratory and Diagnostic Tests; Diagnosis; Medication Record; SELF-ASSESSMENT QUESTIONS; CASE 1.10 Community-Acquired Pneumonia | Level 1; Demographics; Physical Examination 327 $aLaboratory and Diagnostic TestsDiagnosis; Medication Record; SELF-ASSESSMENT QUESTIONS; CASE 1.11 Ventilator-Associated Pneumonia | Level 2; Demographics; Physical Examination; Laboratory and Diagnostic Tests; Diagnosis; Medication Record; SELF-ASSESSMENT QUESTIONS; CASE 1.12 Influenza | Level 2; Demographics; Physical Examination; Laboratory and Diagnostic Tests; Diagnosis; Medication Record; SELF-ASSESSMENT QUESTIONS; CASE 1.13 Tuberculosis | Level 3; Demographics; Physical Examination; Laboratory and Diagnostic Tests; Diagnosis; Medication Record; SELF-ASSESSMENT QUESTIONS 327 $aCASE 1.14 Healthcare-Associated Pneumonia | Level 3Demographics; Physical Examination; Laboratory and Diagnostic Tests; Diagnosis; Medication Record; SELF-ASSESSMENT QUESTIONS; SECTION 4 | Bacteremia, Endocarditis, and Sepsis; CASE 1.15 Neonatal Sepsis | Level 1; Demographics; Physical Examination; Laboratory and Diagnostic Tests; Diagnosis; Medication Record; SELF-ASSESSMENT QUESTIONS; CASE 1.16 Infective Endocarditis-Viridans Group Streptococci | Level 1; Demographics; Physical Examination; Laboratory and Diagnostic Tests; Diagnosis; Medication Record; SELF-ASSESSMENT QUESTIONS 327 $aCASE 1.17 Catheter-Related Bloodstream Infection- Antibiotic Resistance | Level 2 606 $aCommunicable diseases$xChemotherapy$vCase studies 606 $aCommunicable diseases$xChemotherapy$vProblems, exercises, etc 606 $aCommunicable diseases$xDiagnosis$vCase studies 615 0$aCommunicable diseases$xChemotherapy 615 0$aCommunicable diseases$xChemotherapy 615 0$aCommunicable diseases$xDiagnosis 676 $a615.1 700 $aEiland$b Lea S.$01544809 702 $aGinsburg$b Diane B. 712 02$aAmerican Society of Health-System Pharmacists, 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910797488003321 996 $aInfectious disease$93799320 997 $aUNINA